lobbying_activities: 2340131

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2340131	a64ae7cb-33c7-4bf5-8f75-27a678561c5c	3T	MS. TAMI WAHL	401104405	OSRX, INC.	2019	third_quarter	PHA	Worked to ensure appropriate implementation of federal regulations and standards by providing background on pharmacy compounding and updates on imminent concerns to include the Memorandum of Understanding (Food, Drug and Cosmetic Act 503A(b)(3)(B)(ii)) and standards under the FDCA 503A(b)(1).	HOUSE OF REPRESENTATIVES,SENATE			0	1	2019-10-10T16:05:43.990000-04:00